RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..10 of 192 - per page Next page
Order by
Anti-glutamate Receptor GluR3B for Diagnosis, Research and Drug Discovery in Epilepsy
A monoclonal antibody against GluR3B, a peptide found in epilepsy patients, and especially in patients suffering from intractable, resistant forms of the disease, could be used in diagnosis kits as well as in drug development for this form of "autoimmune. More
In Vivo Non-Invasive Diagnostic Method Using Magnetic Resonance Spectroscopy of Aspartate Transaminase
A novel non-invasive method for using carbon-13 magnetization transfer effects to determine and evaluate in vivo aspartate transaminase (AST) activity and levels in an organ, as a biomarker of disease and certain neurological disorders. More
Butylcholinesterase-Binding Compounds for Monitoring and Inhibiting the Progression of Alzheimer's Disease (TID - 42)
These radioactive compounds have the very unique and unprecedented ability to bind very specifically and irreversibly to butyrylcholinesterase (BChE). More
Use of Cripto-1 as a Biomarker for Neurodegenerative Disease and Method of Inhibiting Progression Thereof
Biomarker and possible therapeutic target for a variety of neurodegenerative diseases More
Computer-Aided Gait Analysis for Neuromuscular Diseases (TID - 44)
The Gait-O-Gram can detect and analyze gait information from an individual and, through the use of fuzzy logic algorithms, determine the presence of neuromuscular symptoms. More
A Rapid, Point-of-Care Device for Diagnosis of Acetaminophen Toxicity (08-27)
Acetaminophen-protein Adduct Dipstick: rapid, sensitive and specific diagnostic device for point-of-care determination of acetaminophen toxicity More
Beta-Amyloid PET Imaging Agents
Two novel classes of compounds useful as radioligands for in vivo imaging of beta-amyloid peptides and plaques in humans More
Mouse models to screen for candidates to treat obesity, hyperthyroidism and pain
Transgenic mice for screening compounds with therapeutic potential against pain, hyper-thyroidism or obesity. These transgenic mice over-express DREAM, a transcriptional repressor More
Gadoscan(Gadodiamide)
MRI contast medium More
Radiotracers for Imaging P-glycoprotein Transporter Function
This class of radiotracer is designed to restrict the formation of radiometabolites that would obstruct the measurement of P-gp function at the blood-brain barrier or at tumors. More
Displaying 1..10 of 192 - per page Next page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Deals and alliances in central nervous system diseases
Jun 2006 - 1068 pages - $2,495
Diagnostics Partnering Terms and Agreements
Feb 2012 - 1350 pages - $2,695
Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011
Feb 2011 - 75 pages - $1,000
Central Nervous System Tumors Global Clinical Trial Review, Q4, 2010
Oct 2010 - 53 pages - $1,000
Personalized Medicine Partnering Terms and Agreements
Apr 2011 - 951 pages - $4,995
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Sep 2011 - 97 pages - $3,500
Company Financials: Alexza Pharmaceuticals
Jan 2010 - $75
Emerging Technologies: Stem cells
Nov 2011 - 61 pages - $3,800
Company Financials: Cephalon, Inc
Jan 2010 - $75
Company Financials: Orexigen Therapeutics, Inc.
Jan 2010 - $75
More Related Market Research Reports >>>

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us